INVESTMENT HIGHLIGHTS
TEAM
Connected and well respected in the industry.
PROPRIETARY DEAL FLOW
The DELIC team is front and center in the psychedelic space. We see the best deals, first.
PRIVATE EQUITY MODEL
Nimble and focused on cash flowing and scalable opportunities as they come.
UNIQUE PLATFORM
Delic Holdings is blazing a new trail. While other emerging companies are focused on patent medicine and big pharma for substances that are largely still illegal, Delic identifies fully-legal opportunities to scale under our big tent of resources and reach.
OPPORTUNITY OVERVIEW
Subscribe to important updates below and receive our latest investor presentation.
THE DELIC DEAL PLATFORM PROCESS
existing portfolio companies
DEAL PIPELINE SUMMARY
Company
Luxury Holistic Health and Wellness Clinic.
Innovator in the usage of psychedelic & novel compounds for therapeutic use. Led by world renowned regenerative medicine specialist with major following in the Silicon Valley. Scalable practice to be expanded in California and then nationwide .
SaaS platform for independent retreat companies.
Platform streamlines clients’ bookings, reservations, accounting, marketing, sales and other back-end administrative needs. Leading SaaS platform in the psychedelic retreat sector.
Sector / Biz Model
Vertically integrated agriculture,
distribution, and retail.
Medical & Wellness
SaaS, e-commerce
Medical (Psychistic)
SaaS platform
Financial Snapshot
~$2m revenue
75% gross margin ~$900k EBIT
~$3m revenue YoY Revenue growth
of over 100% for the past 3 years
$2m ARR 20% MoM growth (pre covid)
$1.2m ARR
Pre revenue
DEAL PIPELINE SUMMARY
Company
Sector / Biz Model
Financial Snapshot
Psilocybin truffle producer & distributor.
Has been operating legally in Western Europe for 30+ years.
Advanced mechanized SOP based cultivation systems.
Distribution network throughout the EU. Has begun developing direct
to consumer online retail.
Vertically integrated agriculture, distribution, and retail.
Insiders 3-year escrow, Non-insiders 16-month pooling agreement
Luxury Holistic Health and Wellness Clinic.
Innovator in the usage of psychedelic &novel compounds for therapeutic use. Led by world renowned regenerative medicine specialist with major following in the Silicon Valley. Scalable practice to be expanded in California and then nationwide .
Medical & Wellness
~$3m revenue YoY Revenue growth of over 100% for the past 3 years
SaaS platform for independent retreat companies.
Platform streamlines clients’ bookings, reservations, accounting,
marketing, sales and other back-end administrative needs.
Leading SaaS platform in the psychedelic retreat sector.
SaaS, e-commerce
$2m ARR 20% MoM growth (pre covid)
Leading psychedelic assisted psychotherapy clinic.
Known as one of the leaders in TMS & Ketamine assisted therapy.
Research has received funding Grant’s from the National Association for
Research in Schizophrenia & Depression, the Scottish Rite Organization,
the Stanley Medical Research Institute and the National Institutes of
Health. Practice to be expanded via telemedicine nationally
Medical (Psychistic)
$1.2m ARR
Comprehensive integrated therapy solution for mental health.
Technology platform giving users access to high level standards of care
and information in addition to individual care practitioners.
SaaS platform
Pre revenue
DELIC Holdings
30,000,000
Insiders 3-year escrow, Non-insiders 16-month pooling agreement
Distribution in Shell
753,500
Free Trading
Shell Co
5,250,000
6-month hold post listing
Transaction Finders Fee
450,000
Free Trading
Proposed Financing
15,000,000 @ $0.20
Free Trading
Basic Outstanding at Listing
51,203,500
$10,240,700 market cap at listing
DELIC Holdings
30,000,000
Insiders 3-year escrow, Non-insiders 16-month pooling agreement
Distribution in Shell
753,500
Free Trading
Shell Co
5,250,000
6-month hold post listing
Transaction Finders Fee
450,000
Free Trading
Proposed Financing
15,000,000 @ $0.20
Free Trading
Basic Outstanding at Listing
51,203,500
$10,240,700 market cap at listing
Solutions
The psychedelic renaissance is back. Just in time to help address the global mental health crises, plant medicines have the potential to help billions of people live happier lives. Thanks to university led and FDA approved studies, North America is leading the way in advancing an industry as psychedelics are becoming globally accepted for therapeutic, medical, and recreational use.
Delic Corp is led by a best-in-class team to advance the new psychedelic renaissance that is upon us. Our founders helped build the multi-billion dollar cannabis industry and aim to do the same in psychedelics as they follow a similar path towards legalization. Our advisors are business leaders from mainstream industries. We are dealmakers uniquely positioned to identify the smartest businesses in the space and scale them.
While other emerging companies are focused on patent medicine and big pharma for substances that are largely still limited by government regulation, Delic Corp is blazing a trail all our own. We are identifying ancillary and fully-legal opportunities like new media, live events, ketamine clinics and large-scale production and bringing them under our big tent of resources and reach.